Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
OM

Outset Medical (OM) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $4.05 -1.0% on the day -73.2% over 12 months 52-week range $2.96 – $15.53

Share price and insider trades

OM closeInsider buyInsider sale
05101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $6,765 on 2025-12-01 · Karen DrexlerSold $7,135 on 2025-11-17 · John L. Brottem, Leslie Trigg, Marc NashSold $9,082 on 2026-01-07 · John L. Brottem, Leslie Trigg, Marc NashSold $21,498 on 2026-01-21 · John L. Brottem, Leslie Trigg, Marc NashSold $26,867 on 2026-02-17 · John L. Brottem, Leslie Trigg, Marc NashSold $28,360 on 2026-05-15 · John L. Brottem, Leslie Trigg, Marc NashSold $46,587 on 2026-08-17 · John L. Brottem, Leslie Trigg, Renee GaetaBought $64,241 on 2026-10-02 · Braden Michael LeonardSold $87,300 on 2026-06-03 · Renee GaetaSold $135,593 on 2026-01-20 · John L. Brottem, Leslie Trigg, Marc NashBought $806,019 on 2026-10-01 · Braden Michael Leonard
Bought, 12 months$870K
Sold, 12 months$369K
Insiders buying1
Insiders selling5

Outset Medical insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $870K and 5 sold $369K of OM stock on the open market.

OM insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $14K sold (4 trades)Q4 2025Q1 2026: $193K sold (12 trades)Q1 2026Q2 2026: $116K sold (4 trades)Q2 2026Q3 2026: $47K sold (3 trades)Q3 2026Q4 2026: $870K bought (2 trades)$870KQ4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026$870K2—0
Q3 2026—0$47K3
Q2 2026—0$116K4
Q1 2026—0$193K12
Q4 2025—0$14K4

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$76.1MMedical Devices
Profit margin-63.1%Revenue growth +0.7%
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit+$122KOn all tracked purchases +14.0%

Summary

Over the past 12 months, 1 Outset Medical, Inc. insider reported open-market purchases totaling $870K, while 5 insiders reported sales totaling $369K. 0 of 23 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

OM stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 5SEC Braden Michael Leonard10% Owner Buy 228,3342,748,035 held (+9%) $3.53 $806K +14.7% —
Oct 5SEC Braden Michael Leonard10% Owner Buy 16,5752,764,610 held (+1%) $3.88 $64K +4.5% —
Aug 18SEC Renee GaetaCFO Sell 4,543180,840 held (−2%) $4.39 $20K -7.7% —
Aug 18SEC Leslie TriggCEO, Chair Sell 3,437194,597 held (−2%) $4.39 $15K -7.7% —
Aug 18SEC John L. BrottemGeneral Counsel Sell 2,63287,475 held (−3%) $4.39 $12K -7.7% —
Jun 5SEC Renee GaetaCFO Sell 17,672113,753 held (−13%) $4.94 $87K -18.0% —
May 19SEC Leslie TriggCEO, Chair Sell 3,44598,874 held (−3%) $3.70 $13K +9.5% —
May 19SEC John L. BrottemGeneral Counsel Sell 2,63830,277 held (−8%) $3.70 $10K +9.5% —
May 19SEC Marc NashEvp Operations R&D & Service Sell 1,58238,393 held (−4%) $3.70 $6K +9.5% —
Feb 19SEC Leslie TriggCEO, Chair Sell 3,361102,342 held (−3%) $3.35 $11K +20.9% —
Feb 19SEC John L. BrottemGeneral Counsel Sell 2,84232,935 held (−8%) $3.35 $10K +20.9% —
Feb 19SEC Marc NashEvp Operations R&D & Service Sell 1,81739,988 held (−4%) $3.35 $6K +20.9% —
Jan 21SEC Leslie TriggCEO, Chair Sell 11,794107,823 held (−10%) $5.12 $60K -20.9% —
Jan 21SEC John L. BrottemGeneral Counsel Sell 9,31436,957 held (−20%) $5.12 $48K -20.9% —
Jan 21SEC Marc NashEvp Operations R&D & Service Sell 5,37542,785 held (−11%) $5.12 $28K -20.9% —
Jan 21SEC Leslie TriggCEO, Chair Sell 2,120105,703 held (−2%) $5.05 $11K -19.8% —
Jan 21SEC John L. BrottemGeneral Counsel Sell 1,18035,777 held (−3%) $5.01 $6K -19.2% —
Jan 21SEC Marc NashEvp Operations R&D & Service Sell 98041,805 held (−2%) $4.98 $5K -18.7% —
Jan 8SEC Leslie TriggCEO, Chair Sell 1,795119,617 held (−1%) $4.27 $8K -5.2% —
Jan 8SEC John L. BrottemGeneral Counsel Sell 22446,271 held (−0%) $4.27 $956 -5.2% —
Jan 8SEC Marc NashEvp Operations R&D & Service Sell 10848,160 held (−0%) $4.27 $461 -5.2% —
Dec 2SEC Karen DrexlerDirector Sell 1,54810,650 held (−13%) $4.37 $7K -7.3% —
Nov 18SEC Leslie TriggCEO, Chair Sell 916121,412 held (−1%) $4.60 $4K -12.0% —
Nov 18SEC John L. BrottemGeneral Counsel Sell 38846,495 held (−1%) $4.60 $2K -12.0% —
Nov 18SEC Marc NashEvp Operations R&D & Service Sell 24748,268 held (−1%) $4.60 $1K -12.0% —

Insiders at Outset Medical, Inc.

InsiderBoughtSoldLast filingScore
Braden Michael Leonard10% Owner $870K — Oct 5, 2026 —
Leslie TriggCEO, Chair — $122K Aug 18, 2026 —
Renee GaetaCFO — $107K Aug 18, 2026 —
John L. BrottemGeneral Counsel — $87K Aug 18, 2026 —
Marc NashEvp Operations R&D & Service — $46K May 19, 2026 —
Karen DrexlerDirector — $7K Dec 2, 2025 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

OM stock: common questions

Are Outset Medical, Inc. insiders buying OM stock?

In the past 12 months, 1 insiders reported open-market purchases of OM worth $870K. The latest was 10% Owner Braden Michael Leonard bought $806K of OM at $3.53 — first open-market purchase in our records.

Are Outset Medical, Inc. insiders selling OM stock?

5 insiders reported sales worth $369K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is OM's 52-week range?

Over the past year OM has traded between $2.96 and $15.53. It last closed at $4.05 on Oct 9, 2026.